Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a...
Staff
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that...
Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement
President & CEO Marc Edwards and Executive Chair Dr. Robert Huizinga Discuss This Strategic OpportunityWINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE...
FendX Announces Granting of United States Patent to Protect REPELWRAP(TM) Film
US Patent Represents FendX's 5th Patent IssuedOakville, Ontario--(Newsfile Corp. - November 14, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB:...
Transforming Healthcare with Real-Time AI Image Analytic
Join us to discover how NVIDIA IGX and SDVoE enable seamless ultra-low latency solutions TAIPEI, Nov. 14, 2024 /PRNewswire/ --...
s.360 Life Underwriting SaaS is enhanced through Strategic Partnership with dacadoo
Samplemed Group, an international pioneer in integrated risk analysis and underwriting solutions, proudly announces its strategic partnership with dacadoo. This...
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
AirNet Resolves Nasdaq Minimum Market Value of Publicly Held Shares Deficiency
BEIJING, Nov. 14, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq:...
CENTR Brands Corp. Announces Effective Date of Consolidation
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or...
AI in Healthcare Market to Grow by USD 20.34 Billion (2024-2028), Driven by Healthcare Digitization, AI-Powered Report Highlights Market Transformation – Technavio
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global artificial intelligence (AI)...
EDETEK Recognized as the highest Major Contender in Everest Group’s 2024 Clinical Data and Analytics Platforms PEAK Matrix® Assessment
PRINCETON, N.J., Nov. 13, 2024 /PRNewswire/ -- EDETEK, Inc., a leading global provider of specialized software and services for the...
St. Joseph’s Health Wins National Patient Safety Award
Total Systems Safety assessment earns St. Joseph's Health facilities the 2024 Safety Excellence Award from ECRI PLYMOUTH MEETING, Pa., Nov....
Raintree Adds Elite Healthcare Tech SaaS Product and Financial Leaders to Executive Team
Jeff Neunsinger (CFO) and Tara Clem (CPO) Join Raintree Systems to Drive Financial Strategy and Product Innovation CHANDLER, Ariz., Nov....
QuikMedic and MyCare Medical Group Launch Partnership
CLEARWATER, Fla., Nov. 13, 2024 /PRNewswire/ -- QuikMedic is continuing its national expansion by launching a new partnership with MyCare...
Health and Wellness Market to Grow by USD 1.93 Trillion (2024-2028), Driven by Rising Focus on Health Programs, AI-Powered Report Highlights Market Evolution – Technavio
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global health and...
Bluespine Raises $7.2 Million in Seed Funding to Help Self-Insured Employers Tackle Medical Overbilling
AI-powered platform enables large employers to discover, recover, and prevent healthcare overspending; Alliant Insurance Services, Mattel among companies using Bluespine...
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial...
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial --...
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue...
Tenon Medical Reports Third Quarter 2024 Financial Results
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3%...